XOMA-Logo-Final.png
XOMA to Present at H.C. Wainwright Global Investment Conference
May 17, 2022 16:05 ET | XOMA Corporation
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA-Logo-Final.png
XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events
May 05, 2022 07:30 ET | XOMA Corporation
Earned a $2 million milestone from Rezolute as it dosed the final patient in a Phase 2 open-label study of RZ358 in patients with congenital hyperinsulinism in early 2022.  Rezolute has announced its...
XOMA-Logo-Final.png
XOMA Declares Quarterly Preferred Stock Dividends
March 21, 2022 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA-Logo-Final.png
XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference
March 10, 2022 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA-Logo-Final.png
XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events
March 08, 2022 07:30 ET | XOMA Corporation
Earned $35 million milestone payment as NIS793 entered Phase 3 clinical study in metastatic pancreatic cancer Received $1.2 million from three milestone payments, two of which were from a single...
XOMA-Logo-Final.png
XOMA to Present at the 42nd Annual Cowen Health Care Conference
March 01, 2022 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA-Logo-Final.png
XOMA to Present at Aegis Capital Corp Investor Conference
February 17, 2022 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA-Logo-Final.png
XOMA Declares Quarterly Preferred Stock Dividends
December 23, 2021 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA-Logo-Final.png
XOMA to Present at Upcoming Investor Conferences
December 21, 2021 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA-Logo-Final.png
XOMA Announces Evolution of Company Leadership and Succession Planning
December 16, 2021 07:30 ET | XOMA Corporation
Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director Company is launching Chief Executive Officer search; Jim...